Claris Bio
Claris Bio is a late-stage biopharmaceutical company that develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
$118M Series B+ ·
Led by Catalio · Source: fundraisingfox.com
Total raised: $175M across 2 sourced rounds
All 2 rounds ↓Signals
About Claris Bio
The company researches and develops recombinant hepatocyte growth factor–based treatments designed to restore corneal structure and function. Its pipeline includes topical ophthalmic biologic candidates for conditions such as neurotrophic keratopathy, limbal stem cell deficiency, and corneal scarring. Claris Bio conducts preclinical and clinical research, translational science, and manufacturing activities.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $118M | fundraisingfox.com | ||
| Series A | $57M | — | ophthalmologybreakingnews.com |
Timeline
- Website created
Founders and team
CA
Clarke Atwell FounderRD
Reza Dana FounderSC
Sunil Chauhan FounderSB
Stephen Brady President and CEOBB
Brian Baum Chief Commercial OfficerHR
Henry Rath Chief Business OfficerSO
Susan Orr Chief Medical Officer
Investors
AAdage Capital Management
AADAR1 Capital Management
AAisling Capital
CCataliolead investor
JJanus Henderson Investors
MMass General Brigham Ventures
NNovo Holdings
RRA Capital Management
SSamsara Biocapitallead investor
SSofinnova Partners
Companies like Claris Bio
AActio Biosciences$66M Series B+ · Jun 2025
DDraig Therapeutics$65M Series B+ · Jul 2026
AAlzheon$100M Series B+ · Apr 2022
BBiossil$153M Seed · Sep 2026
LLenzSeries B+ · Mar 2023AAspen Neuroscience$115M Series B+ · Nov 2025
Other companies backed by Catalio
SStar Therapeutics$200M Series B+ · Oct 2026
OOpenEvidence$250M Series B+ · Sep 2026
EEnveda$311M Series B+ · Sep 2026
EEvvy$40M Series B+ · Sep 2026
AAdvanCell$315M Series B+ · Jul 2026
LLeo Cancer Care$65M Series B+ · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/claris-bio (get a free API key).